[{"address1": "2450 Holcombe Boulevard", "address2": "Suite X", "city": "Houston", "state": "TX", "zip": "77021", "country": "United States", "phone": "832 834 9144", "website": "https://www.salariuspharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Salarius Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing treatments for cancers with unmet medical need. Its lead candidate is Seclidemstat (SP-2577), a small molecular inhibitor which is in Phase I/II clinical trial for the treatment of advanced solid tumors, as well as Ewing sarcoma. The company also offers SP-3164, a small molecular protein degrader for the treatment of hematological and solid tumors. It has a strategic partnership with The University of Utah Research Foundation for the exclusive license with respect to patent rights protecting SP-2577 and related compounds and Cancer Prevention and Research Institute of Texas for product development activities. The company is headquartered in Houston, Texas.", "fullTimeEmployees": 2, "companyOfficers": [{"maxAge": 1, "name": "Mr. David J. Arthur M.B.A.", "age": 61, "title": "CEO, President & Director", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 726185, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark J. Rosenblum CPA", "age": 71, "title": "Executive VP of Finance & CFO", "yearBorn": 1953, "fiscalYear": 2024, "totalPay": 339050, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.92, "open": 0.86, "dayLow": 0.8121, "dayHigh": 0.907, "regularMarketPreviousClose": 0.92, "regularMarketOpen": 0.86, "regularMarketDayLow": 0.8121, "regularMarketDayHigh": 0.907, "payoutRatio": 0.0, "beta": 0.592, "forwardPE": -0.09400218, "volume": 110190, "regularMarketVolume": 110190, "averageVolume": 2277891, "averageVolume10days": 719090, "averageDailyVolume10Day": 719090, "bid": 0.63, "ask": 1.07, "bidSize": 2, "askSize": 2, "marketCap": 1489536, "fiftyTwoWeekLow": 0.809, "fiftyTwoWeekHigh": 7.2, "fiftyDayAverage": 1.54606, "twoHundredDayAverage": 1.79553, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -707842, "profitMargins": 0.0, "floatShares": 1610104, "sharesOutstanding": 1728000, "sharesShort": 40435, "sharesShortPriorMonth": 10411, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0234, "heldPercentInsiders": 0.02078, "heldPercentInstitutions": 0.047519997, "shortRatio": 0.22, "shortPercentOfFloat": 0.0235, "impliedSharesOutstanding": 1915290, "bookValue": 1.049, "priceToBook": 0.82173496, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -5575777, "trailingEps": -5.79, "forwardEps": -9.17, "lastSplitFactor": "1:8", "lastSplitDate": 1718582400, "enterpriseToEbitda": 0.124, "52WeekChange": -0.7818826, "SandP52WeekChange": 0.06429911, "quoteType": "EQUITY", "currentPrice": 0.862, "recommendationKey": "none", "totalCash": 2434528, "totalCashPerShare": 1.395, "ebitda": -5729892, "totalDebt": 221866, "quickRatio": 1.611, "currentRatio": 1.977, "debtToEquity": 14.677, "returnOnAssets": -0.74592, "returnOnEquity": -1.6401801, "freeCashflow": -2959250, "operatingCashflow": -4525337, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SLRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1422541800000, "postMarketChangePercent": -6.02088, "postMarketPrice": 0.8101, "postMarketChange": -0.0519, "regularMarketChange": -0.058000028, "regularMarketDayRange": "0.8121 - 0.907", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 2277891, "fiftyTwoWeekLowChange": 0.052999973, "fiftyTwoWeekLowChangePercent": 0.06551295, "fiftyTwoWeekRange": "0.809 - 7.2", "fiftyTwoWeekHighChange": -6.338, "fiftyTwoWeekHighChangePercent": -0.88027775, "fiftyTwoWeekChangePercent": -78.188255, "dividendDate": 1563753600, "earningsTimestamp": 1742817601, "earningsTimestampStart": 1747080000, "earningsTimestampEnd": 1747425600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -5.79, "epsForward": -9.17, "regularMarketChangePercent": -6.3043504, "regularMarketPrice": 0.862, "shortName": "Salarius Pharmaceuticals, Inc.", "longName": "Salarius Pharmaceuticals, Inc.", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1743200917, "regularMarketTime": 1743192001, "exchange": "NCM", "messageBoardId": "finmb_330031056", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "fiftyDayAverageChange": -0.68406, "fiftyDayAverageChangePercent": -0.4424537, "twoHundredDayAverageChange": -0.93353, "twoHundredDayAverageChangePercent": -0.5199189, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "displayName": "Salarius Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-03-29"}]